logo

FATE

Fate Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
3.39 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Should I Buy FATE Now?
  • Based on a composite score of 3.39/10, we rate FATE as a Netural. Our analysis breaks down into 3.65/10 for Fundamentals, 1.99/10 for Technicals, and 3.95/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is FATE fundamentally strong?
What is the current technical signals for FATE?
What is the market sentiment for FATE?